gerdwordtitle.gif (8552 bytes)
 Committed To The Support Of Parents With Children Suffering From GERD and Related Motility Disorders         

zziarp2.gif (3742 bytes)

        mk_120ned1.gif (4260 bytes) 

 

 

Use this link to order from Amazon.com and IARP will receive a donation.

amazon.gif (2019 bytes)

 

aboutiarp.gif (1404 bytes)

refluxinfo.gif (1555 bytes)

dealing.gif (1589 bytes)

drreferrals.gif (1572 bytes)

messageboard.gif (1882 bytes)

chat.gif (1704 bytes)

gerdchild.gif (1712 bytes)

newsletter.gif (1661 bytes)

products.gif (1489 bytes)

support.gif (1641 bytes)

funstuff.gif (1295 bytes)

commontesting.gif (1602 bytes)

contact.gif (1335 bytes)

 

 

 

 

 

December Newsletter & Notes From Nancy

 

Hello!  I hope that you all had a Happy Thanksgiving!  This has been a very busy and exciting month for me.  

I now need to ask for your help.  The filing fees for IARP are going to add up to around $500 and I can't pay these fees all by myself.   Paul has told me that any donations we receive will be tax deductible for the donator since we are pending tax exempt.  If you can give a little bit, please do to help me continue this web site and do even more to help support you and parents like you.   Contact me if you would like to make a donation.  Email:  Nancy

I've run across some very interesting articles this month and have included them here.

Have a very Merry Christmas and safe New Year!   I'll write you again in 1999!

Love,  Nancy

Founder, International Association of Reflux Parents & Refluxmoms Mailing list

 

To go to newsletters from previous months, click here:  November Newsletter


1:  Eosinophilic Gastroenteritis, discussed.

2:  Management of GERD

3:  HOPKINS RESEARCHERS EXPLORE NEW WAYS TO TREAT CHILDREN'S REFLUX

4:  An Interesting Email that I received, perhaps worth investigation?


1:  Eosinophilic Gastroenteritis:

- Clinical:

The condition may be related to an allergic or immunologic cause as symptoms tend to follow ingestion of certain foods and affected patients tend to have history of food allergy. In this condition there is extensive infiltration of one or all layers (mucosa, submucosa, muscular layers, and serosa) of the stomach and/or small bowel by eosinophils. Symptoms include epigastric pain, vomiting, and diarrhea. Patients also develop a protein losing enteropathy due to increased mucosal permeability which results in hypoalbuminemia and hypo-gammaglobulinemia. Peripheral eosinophilia is found in 60% of cases. The disease is generally self-limited with spontaneous remission. Treatment consists of steroids and removal of sensitizing agent.

- X-ray:

On UGI acutely there are diffusely enlarged folds, typically limited to the distal stomach, but the duodenum and small bowel are also involved in 50% of cases. There is a characteristic 'saw tooth' appearance to the small bowel, especially the jejunum. The bowel is typically rigid, but returns to normal following therapy. Multiple nodules may be seen if there is predominantly submucosal infiltration. Chronically, the antrum becomes contracted with a cobblestone appearance. There is a narrowed, nodular pylorus and antrum (distal stomach) with duodenal extension.


2:  Teaching Files:
Management of Gastro-Esophageal Reflux (GER) in Newborns

Rationale Document for CSMC Clinical Guideline 95-242-G.

Prepared by Peggy Ordonez, RN, NNP, Cedars-Sinai Medical Center, Los Angeles, California.
------------------------------------------------------------------------

Incidence and Definition

GER, or the backward flow of gastric contents into the esophagus, may occur as a single event or as a chronic condition. In infants, it may be physiologic or present with pathologic symptoms. Reflux disease in older children, once established tends to persist, whereas reflux in infants generally resolves during the first year of life with or without treatment (Carre, IJ, 1979; Shepherd, RW,Wren, J, Evans, S, et al, 1987). The spitting up of normal newborns that accompanies burping is a common event identified to parents as part of newborn care, and is a normal process. It has been suggested that a smaller ratio of esophageal to gastric volume may be responsible for this (Orenstein, SR, 1991).

The ability to quantify how many episodes of reflux in a given time frame is normal for infants has been fraught with difficulties and controversy. Mainly the difficulty deals with the diagnostic testing for reflux, for which the gold standard is pH probe monitoring. Since the staple diet of an infant is milk, this provides a buffer and it makes it impossible to detect changes in pH unless the stomach has emptied. Use of apple juice with its acidic pH has been practiced, but the results cannot be reliably applied to formula, as the esophagus probably does not process the two solutions in the same manner.

There are some norms that have been published based on age that report means in percentage of recorded time spent with pH equal to or less than 4, and also number of reflux episodes lasting longer than 5 minutes (Orenstein, SR 1991). Symptomatic reflux, however, can be quantified and evaluated. In a study reported by Hrabovsky & Mullett, 1986, they reported the incidence in their preterm population as 2.8% (22 cases out of 760 admissions). The current literature does not offer any other citations of percentage of occurences in the preterm population.

In general, reflux can be divided into physiologic, symptomatic or pathologic. Physiologic GER describes the normal newborn infant who spits up with burps, continues to feed well, grows well and thrives. Symptomatic reflux includes those infants who have some spectrum of observable events that occur that lead one to suspect GER is present. Symptoms include frequent vomiting (> 2 times a day for more than 2 days), which may be effortless drooling of formula from the mouth or projectile vomiting, increasing tracheal secretions, hypoxia or desaturations, recurrent episodes of pneumonia, stridor, recurrent cough or wheezing, apneic and/or bradycardic episodes, and irritability with feeding (Dalt, Mazzoleni, Montini, et al, 1989, Orenstein, 1991). Pathologic reflux is significant enough that it produces a detrimental physical change, such as poor weight gain, mucosal ulceration, or chronic respiratory symptoms not due to known causes.

Pathophysiology

The esophagus is a muscular tube lined with squamous epithelium and separated from the pharynx above and the stomach below by tonically closed sphincters. Its main function is to convey ingested material from the mouth to the stomach. The sphincters must open many times a day to allow swallowed material into the stomach, to vent swallowed air and to allow the occassional regurgitation of noxious gastric material. In the adult, physiologic reflux episodes are brief and occur approximately 5 times in the postprandial hour; their frequency decreases rapidly to a baseline of close to zero about 1 or 2 hours post prandially (Jolley, Herbst, Johnson, et al, 1981). Based on research reported by Dalt and group, 1989, asymptomatic infants reflux about 24 times in 24 hours. Mean time spent refluxing was 1.3%. Pediatric radiologists consider an upper GI to be significant for reflux if there are more than 2 episodes of reflux in a 5 minute period.

Pathologic reflux occurs when the reflux events increase in frequency or duration, when the refluxed material is not cleared from the esophagus, when the refluxed material is regurgitated and caloric loss ensues, or when the refluxate is noxious to the esophageal mucosa and causes esophagitis. Factors that contribute to GER disease in infants include, but are not limited to:

•limited gastric volume and delayed gastric emptying time;                                                                                              •increases in gastric pressure due to abdominal breathing;                                                                                               •transient lower esophageal sphincter relaxations;                                                                                                       •gravitational effects due to positioning;                                                                                                                                 •upper esophageal sphincter dysfunction/ uncoordination; and                                                                                             •drugs that are commonly used in newborns that decrease lower esophageal sphincter tone.

GER may produce pathologic states including:

•esophagitis leading to mucosal ulceration, strictures, vomiting and poor feeding;                                                      •aspiration pneumonia;                                                                                                                                                             •stridor or wheezing from reactive airways;                                                                                                                   •obstructive apnea and bradycardia; and                                                                                                                              •increased risk of sudden infant death.

Diagnosis

The diagnosis of GER may be made based on a combination of clinical symptoms and history plus diagnostic work up. Diagnostic tests include:

Extended pH probe monitoring: This is considered the gold standard for diagnosis (Orenstein, 1991). Recent research literature cites pH monitoring as 100% sensitive and 94% specific (Dalt, 1989). 24 hour monitoring is felt to be necessary to establish an accurate record. Definition of a reflux episode varies from a drop in pH less than or equal to 4 lasting at least 8 seconds (Dalt, 1989) to at least 15 seconds (Society Statement of the Working Group of European Society of Pediatric Gastroenterology and Nutrition, 1992).

The number of reflux episodes considered as normal has not been well established. A descriptive study of 509 healthy full term babies who were being screened for risk of SIDS because they were siblings of SIDS infants, has been published by Vandenplas et al, 1991 and presents data from 24 hour pH monitoring of these asymptomatic infants. This may be as close as we can get to a good study of what is "normal" for physiologic reflux in infants. 95% of these infants had a reflux index (percentage of total investigation time with pH < 4) of 10, with 72 reflux episodes documented, 9 of which were longer than 5 minutes duration, with the longest duration 41 minutes. This study also reports some norms that are age related and may be helpful in the interpretation of pH probe studies. What may be more important is the clinical events that occur when reflux happens. Interpretation of pH probe results need to be considered with clinical symptoms and should only be done by a certified pediatric gastroenterologist familiar with the infants clinical history and symptoms.

Upper GI/Barium swallow: Important to obtain in infants who present with vomiting in order to identify strictures, webs, pyloric stensosis, malrotations of UGI tract, or dysmotility of upper esophageal sphincter. It may also identify severe esophagitis. This is also necessary to perform when there is no clinical presentation of vomiting but diagnosis of GER is made by pH probe study, in order to rule out an organic cause for the GER.

Technetium scintigraphy: This is useful for identifying refluxate that is nonacidic that a pH probe would not be able to detect. Radiation exposure is less than with barium swallow. However, sensitivity is reported to be 59-93% with differences being ascribed to technique. Regurgitant reflux is frequently missed. Gastric emptying time can be quantified, and an abnormal study is defined as more than 50% of marker retained in stomach after 60 to 90 minutes (Fonkalsrud, Berquist, Vargas et al, 1987).

Endoscopy: This may be performed in infants greater than 2 kg. It is useful in diagnosing esophagitis and may preclude the need to perform a pH probe study.

Esophageal manometry: Use is limited to infants with symptoms of esophageal dysmotility.

Three channel pneumocardiogram: For infants who present with symptoms of apnea, this study combines pH probe with heart rate and breathing patterns.

Indications for GI Consult

1.To assist the primary care physician in clarifying whether GER is responsible for the symptom in question. Examples would be apnea or recurrent aspiration.

2.Infant is believed to require an esophageal pH probe.

3.Reflux not responsive to the medical management of the attending physician.

4.Anatomic abnormality of the GI tract.

5.Fundoplication is contemplated.

6.GI tract bleeding is present.

Management

Conservative medical management refers to attention to positioning, thickened feedings and small volume feeds. Recent literature questions the efficacy of any of these measures, and generally are performed on those infants with mild or suspected GER, who do not have any pathologic disease.

Pharmacologic therapy is added once diagnostic work up supports the clinical diagnosis and is usually in the form of a prokinetic agent such as metaclopramide and addition of an H2 blocker such as cimetadine or ranitidine if esophagitis is also suspected. Bethanecol has respiratory side effects in infants with asthma and is usually not used in the premie NICU population. Metaclopramide (Reglan) can cause central nervous system disturbances when used in range of 0.3mg/kg/dose. It is recommended that Reglan be used at a starting range of 0.1 mg/kg/dose every 6 hrs and may be increased to 0.2 mg/kg/dose. Doses of 0.3 mg/kg/dose have been safely tolerated but also known to cause some dyskinetic movements, so need to be used with caution in the higher dose range. Cisapride is another prokinetic drug that has the same side effects of Reglan and Bethanecol, but side effects are seen less often. It is now available for use, but is not approved by the FDA as therapy for GER. In the future, treatment with Cisapride may replace Reglan as clinical experience with this drug increases. GI consult should be obtained if contemplating using this drug.

Medical management is appropriate in the infant with moderate reflux symptoms. Medical therapy should be re evaluated after 2 months. Severe reflux symptoms which include aspiration pneumonia, recurrent failures to remain extubated, significant apnea or bradycardia, and poor weight gain, may benefit from surgical intervention. Publication of data from Dalt, 1989, reports little success in medical management of GER in infants with pH probe study results of > 20 episodes of reflux longer than 5 minutes or reflux time > 27%. The procedure of choice is a Nissen fundoplication. There has been a high incidence of delayed gastric emptying in infants needing fundoplication (Fonkalsrud, 1987), therefore, a technetium gastric emptying study or milk scan may be considered prior to fundoplication in order to rule out the need for concurrent pyloroplasty.

Infants with dysmotility syndromes documented on cine swallow studies may benefit from percutaneously placed gastrojejunal tubes rather than fundoplication (Albanes, 1992).

Please note that the North American Society for Pediatric Gastroenterology and Nutrition is currently developing guidlines for management of GER, and once these are finalized, this current document will be reviewed with respect to consider this group's recommendations.


3: HOPKINS RESEARCHERS EXPLORE NEW WAYS TO TREAT CHILDREN'S REFLUX


November 8, 1995(Couldn't find anything on this that was more recent)

Johns Hopkins Children's Center researchers speculate that food allergies -- those not detected with standard tests -- might be the cause of some gastrointestinal problems in children. If proven, their allergy theory could introduce new ways to evaluate and treat kids for problems like severe nausea, pain, vomiting and poor weight gain.

Currently, these children receive medication to stop acid production and even surgery to stop acid regurgitation. According to the study, however, acid reflux may not be the problem at all and treatment may be as simple as restricting certain foods. The study appears in the November issue of Gastroenterology.

"Previously, these children were tested for food allergies, but traditional skin tests were negative," says Kevin Kelly, M.D., who directed the study when he was at Hopkins. "When they didn't improve with common therapies, we tried to approach the problem from a different perspective."

According to Kelly, biopsies of 10 patients revealed eosinophil cells in the esophagus, a common sign of acid reflux.

"We originally thought that the eosinophils were present because of acid production and reflux. Because of this study, we now think that they are the result of a hypersensitive reaction to ingesting food proteins," he says.

To prove their theory, the researchers took away most foods and placed the children, ages 8 months to 12 years, on an amino-based formula for an average of 17 weeks. The formula is free of the proteins that trigger allergic responses but provides adequate daily calories with the proper distribution of carbohydrates, fats, vitamins, and minerals for growth.

In addition to the formula, patients were allowed clear liquids and foods made from apples and corn, since children rarely are allergic to them.

During the trial, eight of 10 patients quickly became free of chronic gastrointestinal complaints and two reported substantial improvement. Biopsies showed lower or no eosinophils in all 10 patients.

To further support the allergic hypothesis, the patients were gradually reintroduced to specific foods, such as milk, soy, wheat, peanuts, and eggs. The gastrointestinal symptoms were recreated in 9 of the 10 patients, by one or more of these foods. When the allergy-causing food was identified and eliminated, patients again improved. Eight of the 10 patients eventually stopped chronic anti-reflux medications.

Kelly says that although these amino-based formulas are reasonable tools to uncover allergies, further studies need to be done to determine just how protein sources in the diet interact with the gastrointestinal tract.

Kelly is now director of pediatric gastroenterology at St. Christopher's Hospital for Children in Philadelphia.

Other Hopkins researchers involved in this study include: Jay Perman, M.D., professor of pediatrics; Peter Rowe, M.D., associate professor of pediatrics; Hugh Sampson, M.D., professor of pediatrics; and John Yardley, M.D., professor of pathology. Audrey Lazenby, M.D., a former Hopkins assistant professor of pathology, is now at the University of Alabama at Birmingham.

Funding was provided by the National Institutes of Health, the National Institutes for Allergy and Infectious Diseases, and Scientific Hospital Supplies, Inc. in Gaithersburg, MD, who provided the formula. This study also was supported by Hopkins Pediatric Clinical Research Unit.


4: Alternative Therapy for GERD--Perhaps worth some investigation?

I have been diagnosed with Gerd and have had this disorder for over a year now.For the first 3 months I tried the losec and tagament methods of control, call me cheap but who can afford the cost of these drugs.
I went to a new family doctor who also happens to be a herbalist. I asked him if there was anything else I could do to control this disorder with out all the drugs. There is a way and the reason I am emailing you is because I can not imagine being a small child and having to live with this. I have been on FOOD therapy for 1 year now and have had NO problems with any symptoms of pain. The food therapy method is very easy and affordable since we all have to eat anyway, and it is for all ages.

My daily diet consists of 1 serving of Astro yogurt(has a high content of live bacteria) a day.
For those people that can not stomach the thought of eating yogurt if you can buy this brand do so, I have people who hate yogurt eating this stuff. You can also eat a couple of fresh slices of pineapple after a meal
or papaya. If you don't like any of these foods than take digestive enzymes. You can buy Papaya of Bromelien enzymes at most health food stores and you just have acouple of these after a meal.
You must avoid all caffeine when you choose the food therapy method or you will still suffer with the pain. Coffee, Cola's and to much chocolate are a big problem with this type of therapy. I have shared
this method with several people with GERD and it seems to help others just as it has helped me.
On another note I noticed that you listed antacids to cope with this problem and I have found the only one that really will help is Gavascon.(NOTE:--DON'T KNOW IF IT"S OKAY FOR PEDIATRIC USE) On their label it actually mentions GERD relief. I hope that you would consider sharing this method with the thousands
of people that suffer with this disorder.

B. Reed
Alberta Canada

1